Digoxin and Buprenorphine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Digoxin (digoxin) and Buprenorphine hydrochloride (buprenorphine hydrochloride). Common drug interactions include coronary artery disease among females and cardiomyopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Digoxin and Buprenorphine hydrochloride. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.

What is Buprenorphine hydrochloride?

Buprenorphine hydrochloride has active ingredients of buprenorphine hydrochloride. It is often used in pain. eHealthMe is studying from 4,438 Buprenorphine hydrochloride users. Check the latest studies of Buprenorphine hydrochloride.



On Aug, 09, 2026

11 people who take Digoxin and Buprenorphine hydrochloride together, and have interactions are studied.

Digoxin and Buprenorphine hydrochloride drug interactions.

What are the common drug interactions of Digoxin and Buprenorphine Hydrochloride, by gender? *:

female:

  1. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  2. Haematuria present (presence of blood in urine due to trauma)
  3. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  4. Mitral valve incompetence (inefficient heart valve)
  5. Pulmonary oedema (fluid accumulation in the lungs)
  6. Ventricular hypertrophy (enlargement of ventricles (lower chambers) in the heart)
  7. Cardiac disorder
  8. Echocardiogram abnormal
  9. Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)

male:

  1. Cardiomyopathy (weakening of the heart muscle)
  2. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  3. Diarrhoea
  4. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Hypokalaemia (low potassium)
  7. Pericardial effusion (fluid around the heart)
  8. Pneumonia
  9. Post procedural complication
  10. Pyrexia (fever)

What are the common drug interactions of Digoxin and Buprenorphine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Arrhythmia (irregular heartbeat)
  2. Blood potassium abnormal
  3. Bone marrow depression (decreased ability or inability of the bone marrow to produce blood cells)
  4. Budd chiari syndrome (problem that results from blood clotting in the veins flowing out of the liver (hepatic veins))
  5. Cardiac failure
  6. Cardiac tamponade (fluid accumulates in heart covering)
  7. Diarrhoea
  8. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Hypokalaemia (low potassium)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  2. Cardiomyopathy (weakening of the heart muscle)

60+:

  1. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  2. Haematuria present (presence of blood in urine due to trauma)
  3. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  4. Mitral valve incompetence (inefficient heart valve)
  5. Pulmonary oedema (fluid accumulation in the lungs)
  6. Ventricular hypertrophy (enlargement of ventricles (lower chambers) in the heart)
  7. Cardiac disorder
  8. Echocardiogram abnormal
  9. Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)

What are the existing conditions these people have? *

  1. Sedation: 4 people, 36.36%
  2. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 27.27%
  3. Urination - Excessive Volume: 2 people, 18.18%
  4. High Blood Pressure: 2 people, 18.18%
  5. Bleeding Disorders: 2 people, 18.18%
  6. Blood Calcium Decreased: 2 people, 18.18%
  7. Blood Glucose Increased: 2 people, 18.18%
  8. Blood Potassium Decreased: 2 people, 18.18%
  9. Cardiac Failure: 2 people, 18.18%
  10. Constipation: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Digoxin and Buprenorphine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Digoxin and Buprenorphine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Digoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Buprenorphine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Digoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Buprenorphine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on digoxin and buprenorphine hydrochloride (the active ingredients of Digoxin and Buprenorphine hydrochloride, respectively), and Digoxin and Buprenorphine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: